Biosimilar drugs : concerns and opportunities.

Biosimilar drugs : concerns and opportunities.

Item
http://www.wikidata.org/entity/Q37004574
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based StudyHow Much Are Biosimilars Used in Clinical Practice? A Retrospective Italian Population-Based Study of Erythropoiesis-Stimulating Agents in the Years 2009-2013.The impact of rheumatoid arthritis and biologics on employers and payers.Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars.Antibody engineering to develop new antirheumatic therapies.The Role of Biosimilars in Inflammatory Bowel Disease.New and generic anticoagulants and biosimilars: safety considerations.Similar biotherapeutic products: overview and reflections.Managing unexpected events in the manufacturing of biologic medicines.Clinical experience with Zarzio® in Europe: what have we learned?Drift, evolution, and divergence in biologics and biosimilars manufacturing.Biosimilar monoclonal antibodies: the scientific basis for extrapolation.How did the Introduction of Biosimilar Filgrastim Influence the Prescribing Pattern of Granulocyte Colony-Stimulating Factors? Results from a Multicentre, Population-Based Study, from Five Italian Centres in the Years 2009-2014.Where generics and biologics meet.How much are biosimilars used in southern Italy?: a retrospective analysis of epoetin utilization in the local health unit of Messina in the years 2010-2011.Prevalence of Use and Cost of Biological and Non-Biological Targeted Therapies for Cancer Treatment: A 5-Year Picture from Southern Italy.Biologicals and biosimilars: safety issues in Europe.
P2860

Biosimilar drugs : concerns and opportunities.

Item
http://www.wikidata.org/entity/Q37004574
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biosimilar drugs : concerns and opportunities.
@en
Biosimilar drugs : concerns and opportunities.
@nl
type
label
Biosimilar drugs : concerns and opportunities.
@en
Biosimilar drugs : concerns and opportunities.
@nl
prefLabel
Biosimilar drugs : concerns and opportunities.
@en
Biosimilar drugs : concerns and opportunities.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Biosimilar drugs : concerns and opportunities.
@en
P2093
P2888
P304
P31
P356
10.2165/00063030-200721060-00003
P433
P478
P50
P577
P6179
P698